Baidu
map

Eur J Heart Fail:较高的血清硒与降低死亡率和新发心衰风险有关

2021-12-22 MedSci原创 MedSci原创

血清硒浓度与代谢综合征的多项指标独立相关。此外,血清硒水平较高与非吸烟者死亡率和新发心衰降低独立相关。需要强有力的干预研究来评估补充硒的潜在益处,尤其是对不吸烟人群。

营养不良是一个全球性的健康问题。全世界大约有8亿人患有不同形式的营养不良。这不仅限于营养不足,还包括发展中国家和发达国家因饮食不平衡而导致的特定微量营养素缺乏症。饮食习惯可能在与营养相关的慢性非传染性疾病的发生和预防中发挥重要作用。

近日,心血管领域权威杂志European Journal of Heart Failure上发表了一篇研究文章,研究人员旨在阐明一般成年人群中血清硒水平与死亡和新发心力衰竭风险之间的关系。

在荷兰队列中,研究人员测量了血清硒水平,并对前瞻性评估数据进行了回顾性分析。该研究的主要结局指标分别是全因死亡率和新发心力衰竭(HF)的发生率,并将其联合一起作为复合终点。

在5973名受试者中测量了血清硒水平,血清硒平均浓度为84.6(±19.5)μg/L。平均年龄为53.6(±12.1)岁,3103名受试者(52%)为女性。中位随访时间为8.4年。血清硒水平与女性、较高的总胆固醇和血糖浓度呈正相关,与贫血、缺铁、目前吸烟、C反应蛋白水平升高和较高的体重指数呈负相关。对所有受试者的单变量分析显示,血清硒每增加10μg/L与复合终点之间没有关联(风险比[HR]=0.96,95%置信区间[CI]为0.87-1.06,p=0.407)。然而,研究人员观察到血清硒与吸烟状态之间存在显著的相互作用。在非吸烟受试者(N=4288)中,血清硒浓度与死亡率降低(HR=0.87,95%CI为0.79-0.96,p=0.005)、新发HF风险降低(HR=0.82,95%CI为0.69-0.96,p=0.017)以及复合终点风险降低(HR=0.86,95%CI为0.79-0.94,p=0.001)独立相关。在吸烟受试者中,研究人员没有观察到关联。

由此可见,血清硒浓度与代谢综合征的多项指标独立相关。此外,血清硒水平较高与非吸烟者死亡率和新发心衰降低独立相关。需要强有力的干预研究来评估补充硒的潜在益处,尤其是对不吸烟人群。

原始出处:

Ali A. Al-Mubarak.et al.High selenium levels associate with reduced risk of mortality and new onset heart failure: data from PREVEND.European journal of heart failure.2021.https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2405

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201324, encodeId=699612013247c, content=<a href='/topic/show?id=3333e3516ba' target=_blank style='color:#2F92EE;'>#硒#</a>与<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>又有关联, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73516, encryptionId=3333e3516ba, topicName=硒), TopicDto(id=51926, encryptionId=f5cb5192610, topicName=心衰)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 14:40:15 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083898, encodeId=d6a11083898c9, content=点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Fri Dec 24 13:56:32 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357849, encodeId=257b135e84970, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389489, encodeId=5ceb1389489eb, content=<a href='/topic/show?id=8425519625e' target=_blank style='color:#2F92EE;'>#心衰风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51962, encryptionId=8425519625e, topicName=心衰风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563564, encodeId=f6c31563564f0, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083510, encodeId=1b31108351045, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:12:19 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-03-10 医者仁者

    #硒##心衰#又有关联

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201324, encodeId=699612013247c, content=<a href='/topic/show?id=3333e3516ba' target=_blank style='color:#2F92EE;'>#硒#</a>与<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>又有关联, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73516, encryptionId=3333e3516ba, topicName=硒), TopicDto(id=51926, encryptionId=f5cb5192610, topicName=心衰)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 14:40:15 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083898, encodeId=d6a11083898c9, content=点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Fri Dec 24 13:56:32 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357849, encodeId=257b135e84970, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389489, encodeId=5ceb1389489eb, content=<a href='/topic/show?id=8425519625e' target=_blank style='color:#2F92EE;'>#心衰风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51962, encryptionId=8425519625e, topicName=心衰风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563564, encodeId=f6c31563564f0, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083510, encodeId=1b31108351045, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:12:19 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-24 ms7000002136561391

    点赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201324, encodeId=699612013247c, content=<a href='/topic/show?id=3333e3516ba' target=_blank style='color:#2F92EE;'>#硒#</a>与<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>又有关联, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73516, encryptionId=3333e3516ba, topicName=硒), TopicDto(id=51926, encryptionId=f5cb5192610, topicName=心衰)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 14:40:15 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083898, encodeId=d6a11083898c9, content=点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Fri Dec 24 13:56:32 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357849, encodeId=257b135e84970, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389489, encodeId=5ceb1389489eb, content=<a href='/topic/show?id=8425519625e' target=_blank style='color:#2F92EE;'>#心衰风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51962, encryptionId=8425519625e, topicName=心衰风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563564, encodeId=f6c31563564f0, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083510, encodeId=1b31108351045, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:12:19 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-24 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1201324, encodeId=699612013247c, content=<a href='/topic/show?id=3333e3516ba' target=_blank style='color:#2F92EE;'>#硒#</a>与<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>又有关联, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73516, encryptionId=3333e3516ba, topicName=硒), TopicDto(id=51926, encryptionId=f5cb5192610, topicName=心衰)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 14:40:15 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083898, encodeId=d6a11083898c9, content=点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Fri Dec 24 13:56:32 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357849, encodeId=257b135e84970, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389489, encodeId=5ceb1389489eb, content=<a href='/topic/show?id=8425519625e' target=_blank style='color:#2F92EE;'>#心衰风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51962, encryptionId=8425519625e, topicName=心衰风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563564, encodeId=f6c31563564f0, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083510, encodeId=1b31108351045, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:12:19 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1201324, encodeId=699612013247c, content=<a href='/topic/show?id=3333e3516ba' target=_blank style='color:#2F92EE;'>#硒#</a>与<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>又有关联, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73516, encryptionId=3333e3516ba, topicName=硒), TopicDto(id=51926, encryptionId=f5cb5192610, topicName=心衰)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 14:40:15 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083898, encodeId=d6a11083898c9, content=点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Fri Dec 24 13:56:32 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357849, encodeId=257b135e84970, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389489, encodeId=5ceb1389489eb, content=<a href='/topic/show?id=8425519625e' target=_blank style='color:#2F92EE;'>#心衰风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51962, encryptionId=8425519625e, topicName=心衰风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563564, encodeId=f6c31563564f0, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083510, encodeId=1b31108351045, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:12:19 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-24 slcumt
  6. [GetPortalCommentsPageByObjectIdResponse(id=1201324, encodeId=699612013247c, content=<a href='/topic/show?id=3333e3516ba' target=_blank style='color:#2F92EE;'>#硒#</a>与<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>又有关联, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73516, encryptionId=3333e3516ba, topicName=硒), TopicDto(id=51926, encryptionId=f5cb5192610, topicName=心衰)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 14:40:15 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083898, encodeId=d6a11083898c9, content=点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Fri Dec 24 13:56:32 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357849, encodeId=257b135e84970, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389489, encodeId=5ceb1389489eb, content=<a href='/topic/show?id=8425519625e' target=_blank style='color:#2F92EE;'>#心衰风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51962, encryptionId=8425519625e, topicName=心衰风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563564, encodeId=f6c31563564f0, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri Dec 24 11:08:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083510, encodeId=1b31108351045, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0f5588916, createdName=ms4000001117609205, createdTime=Thu Dec 23 11:12:19 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-23 ms4000001117609205

    学习

    0

相关资讯

Chest:长期吸烟者肌肉丢失与死亡率之间的纵向关联

无论BMI或初始肌肉质量如何,PMA的丢失与全因死亡率增加相关。

Chest:纤维化间质性肺病患者体重指数和体重变化与死亡率之间的相关性

BMI和体重减轻均与纤维化ILD患者的1年死亡率独立相关。BMI和体重减轻可能是临床上有用的纤维化ILD预后指标。

Alzheimers Dement::定期检测糖尿病患者认知功能意义重大

认知障碍与糖尿病患者和非糖尿病患者的死亡率增加有关

JAHA:绝对心血管疾病风险可预测老年人残疾和死亡率

绝对CVD风险与65岁以上人群的残疾和死亡率相关。即使在老年时进行评估,估计的CVD风险水平也可能是残疾和死亡风险的有用替代指标。

JCEM:糖尿病患者体重减轻,竟预示着死神来临?

T2D发病后体重显著减轻与死亡率增加有关,尽管生活方式质量的改善减弱了这些关联。

Clin Trans Gastroenterology:胆汁吸入的危险因素及其对临床结果的影响

食管反流一般指反流性食管炎。 反流性食管炎(RE)是由胃、十二指肠内容物反流入食管引起的食管炎症性病变,内镜下表现为食管黏膜的破损,即食管糜烂和(或)食管溃疡。

Baidu
map
Baidu
map
Baidu
map